New kidney cancer model highlights molecular targets and genomic events that drive metastasis

FHS
June 27, 2023
1:01 am

Researchers at The University of Texas MD Anderson Cancer have engineered a new model of aggressive renal cell carcinoma (RCC), highlighting molecular targets and genomic events that trigger chromosomal instability and drive metastatic progression.

Gilead settles with Maryland distributor over alleged counterfeit HIV drugs

Gilead’s yearslong legal battle against what it said was a trafficker of counterfeit HIV medicines is coming to a close. The pharma company struck a

February 24, 2024

Healthpilot and Publix Partner to Simplify Medicare Plan Selection

What You Should Know: – Healthpilot, an AI-powered Medicare comparison platform, and Publix Supermarkets have joined forces to simplify the process of choosing Medicare plans

November 13, 2024

Agenus launches biologics manufacturing business to generate cash

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

December 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.